(Q34681746)

English

Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

multiple sclerosis

0 references

author name string

Rachel Halpern

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sonalee Agarwal

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Carole Dembek

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Leigh Borton

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Maria Lopez-Bresnahan

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

20 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Patient Preference and Adherence

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

73-84

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Clinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Medication compliance and persistence: terminology and definitions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Adherence to interferon-beta treatment and results of therapy switching

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Methods for evaluation of medication adherence and persistence using automated databases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Estimating medication persistency using administrative claims data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Multiple sclerosis: it's not the disease you thought it was.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

7 July 2018

Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

26 October 2018

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

26 October 2018

Persistence and adherence to disease modifying drugs among patients with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

26 October 2018

Factors that influence adherence with disease-modifying therapy in MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

26 October 2018

Clinical and economic impact of glatiramer acetate versus beta interferon therapy among patients with multiple sclerosis in a managed care population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058604

26 October 2018

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21423591

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancing adherence through education

1 reference

https://pubmed.ncbi.nlm.nih.gov/21423591

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report

1 reference

https://pubmed.ncbi.nlm.nih.gov/21423591

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21423591

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns

1 reference

https://pubmed.ncbi.nlm.nih.gov/21423591

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Introduction: adherence to disease-modifying therapies--key to optimizing outcomes in relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21423591

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Adherence to Interferon β Therapy in Relapsing-Remitting Multiple Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21423591

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helping patients follow prescribed treatment: clinical applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/21423591

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/PPA.S15702

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34681746&oldid=1957158097"